Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Gains from Investment Securities (2016 - 2025)

Zevra Therapeutics' Gains from Investment Securities history spans 11 years, with the latest figure at -$1.6 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$1.6 million; the TTM value through Dec 2025 reached -$451000.0, down 207.64%, while the annual FY2025 figure was -$451000.0, 107.58% down from the prior year.
  • Gains from Investment Securities reached -$1.6 million in Q4 2025 per ZVRA's latest filing, up from -$6.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.4 million in Q1 2025 to a low of -$10.5 million in Q1 2022.
  • Average Gains from Investment Securities over 5 years is -$700600.0, with a median of -$22000.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: surged 13033.33% in 2021, then tumbled 17290.16% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$92000.0 in 2021, then soared by 233.7% to $123000.0 in 2022, then crashed by 175.61% to -$93000.0 in 2023, then skyrocketed by 411.83% to $290000.0 in 2024, then plummeted by 640.0% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Gains from Investment Securities are -$1.6 million (Q4 2025), -$6.2 million (Q2 2025), and $7.4 million (Q1 2025).